This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Holt, D E Articles by Turton, J A Search for Related Content PubMed PubMed Citation Articles by Holt, D E Articles by Turton, J A Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Antibiotics Blood and Blood Disorders Hazardous Substances DB CHLORAMPHENICOL Social Bookmarking                         What's this?

The myelotoxicity of chloramphenicol: in vitro and in vivo studies: II: in vivo myelotoxicity in the B6C3F mouse

The Karim Centre for Meningitis Research, Queen Charlotte's and Chelsea Hospital, London W6 0XG

C M Andrews

Pathology Department, Glaxo Wellcome Research and Development, Park Road, Ware, Herts SG12 0DP

J P Payne

Department of Toxicology, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX

T C Williams

Pathology Department, Glaxo Wellcome Research and Development, Park Road, Ware, Herts SG12 0DP

J A Turton

Department of Toxicology, The School of Pharmacy, University of London, 29-39 Brunswick Square, London WC1N 1AX

1 Chloramphenicol continues to be widely used in many parts of the world despite its known haematotoxicity. Until now, elucidation of the mechanisms involved and any attempt at amelioration of the toxic effects have been hampered by the lack of an animal model.

2 In this study neither acute nor chronic administration of chloramphenicol as its succinate ester in the drinking water produced anaemia in mice as assessed by changes in peripheral blood parameters.

3 Chloramphenicol could not be detected in the bone marrow when the antibiotic was administered either in the drinking water or by gavage, although it was detected in the serum.

4 In marrow taken from mice after chloramphenicol succinate administration and cultured in vitro, depression of the differentiation of immature committed erythroid progenitors occurred 15 min after administration of the antibiotic by gavage. However, recovery was beginning to occur at 48 h after administration of chloramphenicol succinate at 50 and 200 mg/kg and this was then followed by an `overshoot' response at the higher dose. A toxic effect was therefore achieved in the bone marrow but this was probably masked in the peripheral blood by enhanced proliferation.

5 Morphological evidence of apoptosis was seen in erythroid and myeloid precursors in mice treated with 200 mg/kg.

6 The data suggest that the effect of chloramphenicol was at the differentiation stage of the committed marrow progenitor cells rather than at the replication stage of the stem cells and therefore this response appears to mimic the reversible bone marrow depression seen in the treated patient.

Key Words: chloramphenicol • myelotoxicity • mouse • peripheral blood • apoptosis

Human & Experimental Toxicology, Vol. 17, No. 1, 8-17 (1998)
DOI: 10.1177/096032719801700102


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Chen Animal Models for Acquired Bone Marrow Failure Syndromes Clin. Med. Res., May 1, 2005; 3(2): 102 - 108. [Abstract] [Full Text] [PDF]

				J A Turton, D Yallop, C M Andrews, R Fagg, M York, and T C Williams Haemotoxicity of chloramphenicol succinate in the CD-1 mouse and Wistar Hanover rat Human and Experimental Toxicology, September 1, 1999; 18(9): 566 - 576. [Abstract] [PDF]

				Proceedings of the British Toxicology Society Autumn Meeting University of York 20-22 September 1998 Human and Experimental Toxicology, January 1, 1999; 18(1): 46 - 65. [PDF]